학술논문
The outcome of two SMA cases treated with nusinersen at seven hours and at three days of life: the earliest ever
Document Type
Short Communication
Author
Source
In Neuromuscular Disorders July 2022 32(7):575-577
Subject
Language
ISSN
0960-8966